AUTHOR INDEX
 |
|
| Browse by letter: |
|
|
|
|
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
|
|
|
|
|
|
|
|
|
|
Search results for: "K"
Results 11 - 20 of 657 shown below |
|
|
|
|
|
|
|
| Kaddurah-Daouk, Rima |
|
| Rima Kaddurah-Daouk and K Ranga Rama Krishnan Metabolomics: A Global Biochemical Approach to the Study of Central Nervous System Diseases doi:10.1038/npp.2008.174 Neuropsychopharmacology 34, 173-186 | Abstract | Full text | PDF | |
|
|
|
| Kademian, Silvia ME |
|
| Silvia ME Kademian, Anahi E Bignante, Patricia Lardone, Bruce S McEwen and Marta Volosin Biphasic Effects of Adrenal Steroids on Learned Helplessness Behavior Induced by Inescapable Shock doi:10.1038/sj.npp.1300577 Neuropsychopharmacology 30, 58-66 | Abstract | Full text | PDF | |
|
|
|
| Kadotomi, Yoshie |
|
| Cai Song, Xuwen Li, Zhijian Kang and Yoshie Kadotomi Omega-3 Fatty Acid Ethyl-Eicosapentaenoate Attenuates IL-1  -Induced Changes in Dopamine and Metabolites in the Shell of the Nucleus Accumbens: Involved with PLA2 Activity and Corticosterone Secretiondoi:10.1038/sj.npp.1301117 Neuropsychopharmacology 32, 736-744 | Abstract | Full text | PDF | |
|
|
|
| Cai Song, Xuwen Li, Zhijian Kang and Yoshie Kadotomi Omega-3 Fatty Acid Ethyl-Eicosapentaenoate Attenuates IL-1 -Induced Changes in Dopamine and Metabolites in the Shell of the Nucleus Accumbens: Involved with PLA2 Activity and Corticosterone Secretiondoi:10.1038/sj.npp.1301311 Neuropsychopharmacology 32, 1207-1207 | Abstract | Full text | PDF | |
|
|
|
| Kaffenberger, Tina |
|
| Annette Beatrix Brühl, Tina Kaffenberger and Uwe Herwig Serotonergic and Noradrenergic Modulation of Emotion Processing by Single Dose Antidepressants doi:10.1038/npp.2009.159 Neuropsychopharmacology aop, - | Abstract | Full text | PDF | |
|
|
|
| Kafkafi, Neri |
|
| Neri Kafkafi, Daniel Yekutieli and Greg I Elmer A Data Mining Approach to In Vivo Classification of Psychopharmacological Drugs doi:10.1038/npp.2008.103 Neuropsychopharmacology 34, 607-623 | Abstract | Full text | PDF | |
|
|
|
| Kahn, R S |
|
| B N M van Berckel, C Lipsch, S Timp, C Gispen-de Wied, H Wynne, J M van Ree and R S Kahn Behavioral and Neuroendocrine Effects of the Partial NMDA Agonist D-cycloserine in Healthy Subjects doi:10.1016/S0893-133X(96)00196-0 Neuropsychopharmacology 16, 317-324 | Abstract | PDF | |
|
|
|
| Kahn, RS |
|
| BNM van Berckel, CN Evenblij, BJAM van Loon, MF Maas, MAM van der Geld, HJ Wynne, JM van Ree and RS Kahn D-Cycloserine Increases Positive Symptoms in Chronic Schizophrenic Patients When Administered in Addition to Antipsychotics: A Double-Blind, Parallel, Placebo-Controlled Study doi:10.1016/S0893-133X(99)00014-7 Neuropsychopharmacology 21, 203-210 | Abstract | Full text | PDF | |
|
|
|
| B Oranje, BNM van Berckel, C Kemner, JM van Ree, RS Kahn and MN Verbaten The Effects of a Sub-Anaesthetic Dose of Ketamine on Human Selective Attention doi:10.1016/S0893-133X(99)00118-9 Neuropsychopharmacology 22, 293-302 | Abstract | Full text | PDF | |
|
|
|
| Kahn, René S |
|
| Neeltje E M van Haren, Hilleke E Hulshoff Pol, Hugo G Schnack, Wiepke Cahn, René C W Mandl, D Louis Collins, Alan C Evans and René S Kahn Focal Gray Matter Changes in Schizophrenia across the Course of the Illness: A 5-Year Follow-Up Study doi:10.1038/sj.npp.1301347 Neuropsychopharmacology 32, 2057-2066 | Abstract | Full text | PDF | |
|
|
|
| Floortje E Scheepers, Christine C Gispen de Wied, Hilleke E Hulshoff Pol, Wiesje van de Flier, Jeroen A van der Linden and René S Kahn The Effect of Clozapine on Caudate Nucleus Volume in Schizophrenic Patients Previously Treated with Typical Antipsychotics doi:10.1016/S0893-133X(00)00172-X Neuropsychopharmacology 24, 47-54 | Abstract | Full text | PDF | |
|
|
|
| Floortje E Scheepers, Christine C Gispen-de Wied, Herman G M Westenberg and René S Kahn The Effect of Olanzapine Treatment on Monoamine Metabolite Concentrations in the Cerebrospinal Fluid of Schizophrenic Patients doi:10.1016/S0893-133X(01)00250-0 Neuropsychopharmacology 25, 468-475 | Abstract | Full text | PDF | |
|
|
|
| Jacob A S Vorstman, Bruce I Turetsky, Monique E J Sijmens-Morcus, Monique G de Sain, Bert Dorland, Mirjam Sprong, Eric F Rappaport, Frits A Beemer, Beverly S Emanuel, René S Kahn, Herman van Engeland and Chantal Kemner Proline Affects Brain Function in 22q11DS Children with the Low Activity COMT158 Allele doi:10.1038/npp.2008.132 Neuropsychopharmacology 34, 739-746 | Abstract | Full text | PDF | |
|
|
|
Matthijs G Bossong, Bart NM van Berckel, Ronald Boellaard, Lineke Zuurman, Robert C Schuit, Albert D Windhorst, Joop M A van Gerven, Nick F Ramsey, Adriaan A Lammertsma and René S Kahn 9-Tetrahydrocannabinol Induces Dopamine Release in the Human Striatumdoi:10.1038/npp.2008.138 Neuropsychopharmacology 34, 759-766 | Abstract | Full text | PDF | |
|
|
|
| Kahn, Rene S |
|
| Gerry Jager, Maartje M L de Win, Ingeborg van der Tweel, Thelma Schilt, Rene S Kahn, Wim van den Brink, Jan M van Ree and Nick F Ramsey Assessment of Cognitive Brain Function in Ecstasy Users and Contributions of Other Drugs of Abuse: Results from an fMRI Study doi:10.1038/sj.npp.1301415 Neuropsychopharmacology 33, 247-258 | Abstract | Full text | PDF | |
|
|
|
| Farooq Amin, Adriana E Stroe, Thomas Kahn, Peter J Knott, Rene S Kahn and Michael Davidson Control of Renal Factors in Plasma Homovanillic Acid Measurements doi:10.1016/S0893-133X(97)00142-5 Neuropsychopharmacology 18, 317-320 | Abstract | Full text | PDF | |
|
|
|
| Kahn, Roberta |
|
| Thomas F Newton, John D Roache, Richard De La Garza, Timothy Fong, Christopher L Wallace, Shou-Hua Li, Ahmed Elkashef, Nora Chiang and Roberta Kahn Bupropion Reduces Methamphetamine-Induced Subjective Effects and Cue-Induced Craving doi:10.1038/sj.npp.1300979 Neuropsychopharmacology 31, 1537-1544 | Abstract | Full text | PDF | |
|
|
|
| Ahmed M Elkashef, Richard A Rawson, Ann L Anderson, Shou-Hua Li, Tyson Holmes, Edwina V Smith, Nora Chiang, Roberta Kahn, Frank Vocci, Walter Ling, Valerie J Pearce, Michael McCann, Jan Campbell, Charles Gorodetzky, William Haning, Barry Carlton, Joseph Mawhinney and Dennis Weis Bupropion for the Treatment of Methamphetamine Dependence doi:10.1038/sj.npp.1301481 Neuropsychopharmacology 33, 1162-1170 | Abstract | Full text | PDF | |
|
|
|
|
|
|
|
|
|
| Result page | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 | 35 | 36 | 37 | 38 | 39 | 40 | 41 | 42 | 43 | 44 | 45 | 46 | 47 | 48 | 49 | 50 | 51 | 52 | 53 | 54 | 55 | 56 | 57 | 58 | 59 | 60 | 61 | 62 | 63 | 64 | 65 | 66 | |
 Previous
|
Next 
|
|
|
|
|
|
|
top  |
|
|
|
